News Medical on MSN

GLP-1 drugs calm inflammation beyond diabetes and weight loss

This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent ...
News-Medical.Net on MSN

Do GLP-1 drugs cause cancer? New review says no, may even protect

A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and ...
Medscape

GI Safety Similar for Popular Weight-Loss Drugs

Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes, ...
Healio

Oral quadruple receptor agonist confers weight loss with minimal GI adverse events

A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or ...
Health and Me on MSN

Taking Ozempic, Wegovy, or Mounjaro? Experts Warn Of Rare But Severe Reaction

Health officials have issued a warning for Ozempic, Wegovy, Rybelsus, and Mounjaro users after reports of severe reactions linked to GLP-1 drugs. Here’s what the alert means and how to stay safe. Keep ...